Industry Outlook and Trend Analysis
The Blood Viscometer Market has observed significant growth in the recent years and is foreseen to grow tremendously over the forecast period. The estimation of the viscosity of blood is carried out by making use of a blood viscometer. Rheometer measures the viscosity of a liquid with different flow conditions, while, viscometers measure the viscosity with one flow condition. The applications of the blood viscometer are to analyse the viscosity of the blood which is useful in diagnosis of all known hazard factors associated with cardiovascular illnesses, which incorporate smoking, high blood cholesterol, pressure, diabetes and other cardiovascular diseases. This predicts cardiovascular diseases, and eventually, the viscosity of the blood can be enhanced with the assistance of medication. Not just the blood viscometer helps in the forecast of cardiovascular diseases yet additionally, other real sicknesses, for example, migraines, Alzheimer’s disease, rheumatoid arthritis, gout, and diabetes.
Product Outlook and Trend Analysis
On the basis of product the market is segmented into rotational viscometer, capillary viscometer, and others. The convenience in usage, short measuring time, requirement of one run and small test sample volume, viscosity can be judged over a variety of shear rates, and the non-requirement of anticoagulants are factors that boost the adoption of blood viscometers. The development and advancements in research of the blood viscometer have prompted overcoming of the difficulties posed by the customary viscometer or rheometer techniques. This, thus, has prompted the surging demand for these devices, subsequently driving the market for the blood viscometer.
End User Outlook and Trend Analysis
Based on end user the market is segmented into hospitals, laboratories, clinics and others. Rising risk of different cardiovascular diseases, migraines, headaches, Alzheimer’s disease, rheumatoid arthritis, and gout has significantly expanded the interest for blood viscometers over the globe.
Regional Outlook and Trend Analysis
North America rules the worldwide blood viscometer market in 2016, as there are major investments in research and development of blood viscometers which has prompted creation of the progressed and created blood viscometers bringing about whooping impressive interest for blood viscometer products in the locale. The market in Asia Pacific is assessed to expand because of the populace pool particularly in nations like India and China, and spreading awareness about the blood viscometer's wide applications.
The major players in the market are LAMY RHEOLOGY, RheoSense, Health Onvector, Anton Paar, Thermo Fisher Scientific, Benson Viscometers, Brookfield Asset Management and BioFluid Technology. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Blood Viscometer Market is segmented as follows-
By End User:
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?